![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Novartis, Asahi Kasei Pharma to Collaborate in Promoting Voltaren
Novartis, Asahi Kasei Pharma to Collaborate in Promoting Voltaren
Novartis Pharma K.K. and Asahi Kasei Pharma jointly announced that they have agreed to collaborate in promoting Voltaren, a nonsteroidal anti-inflammatory agent. Specifically, the two companies will begin co-promoting four preparations of Voltaren: Voltaren Tablet, Voltaren Suppo, Voltaren SR Capsule, and Voltaren Gel. As for Voltaren Tape, they will continue discussions on possible co-promotion. Initially launched in 1974, Voltaren is currently sold in 140 countries worldwide.
Japan Corporate News Network (http://www.japancorp.net/Article.Asp?Art_ID=9885)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct